BUSINESS: International News Aequus Strengthens Clinical Experience in Stargardt Disease With Pediatric Ophthalmology Expertise By Staff Friday, September 17, 2021 12:02 AM Aequus Pharmaceuticals (Aequus) a specialty pharmaceutical company, announced that Dr. Robert K. Koenekoop MD, MSc, PhD, FRCS(C), FARVO has joined as a medical and clinical consultant to Aequus on inherited retinal diseases, and specifically to support Aequus’ collaboration with reVision Therapeutics for the product REV-0100, a potential therapy for Stargardt disease. Read More